8R-Lisuride Is a Potent Stereospecific Histamine H1-Receptor Partial Agonist

Molecular Pharmacology

Volumn 65, Issue 3, 2004, Pages 538-549

  Bakker, R A ^a,b   Weiner, D M ^b,d   Ter Laak, T ^a,e   Beuming, T ^a,f   Zuiderveld, P ^a   Edelbroek, M ^a   Hacksell, U ^b   Timmerman, H ^a   Brann, M R ^b,c   Leurs, R ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ACADIA PHARMACEUTICALS INC   (United States)

^c San Diego   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL PHOSPHATE; LISURIDE; NEUROLEPTIC AGENT;

ALLERGIC DISEASE; ANIMAL CELL; ARTICLE; DRUG ACTIVITY; DRUG BINDING; DRUG DETERMINATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TOLERABILITY; HUMAN; HUMAN CELL; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIDE EFFECT; STEREOSPECIFICITY;

3T3 CELLS; ANIMALS; BINDING SITES; CLONING, MOLECULAR; DNA MUTATIONAL ANALYSIS; ERGOLINES; HELA CELLS; HISTAMINE AGONISTS; HUMANS; LISURIDE; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; RECEPTORS, HISTAMINE H1; SEROTONIN AGONISTS;

EID: 10744221113     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.3.538     Document Type: Article

References (59)

1. Allain H, Destee A, Petit H, Patay M, Schuck S, Bentue-Ferrer D, and Le Cavorzin P (2000) Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease. The French Lisuride Study Group. Eur Neurol 44:22-30.
2. Arrang JM, Garbag M, Quach TT, Trung Tuong MD, Yeramian E, and Schwartz JC (1985) Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 111:73-84.
3. 1-antihistamines in humans. Clin Allergy Immunol 17:101-139.
4. q/11-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 60:1133-1142.
5. 1 receptor antagonists. Eur J Pharmacol 387:R5-R7.
6. Batzri S and Dyer J (1982) Direct action of D-lysergic acid diethylamide on dispersed mucosal cells from guinea pig stomach. Biochem Pharmacol 31:2676-2679.
7. Bayly CI, Cieplak P, Cornell WD, and Kollman PA (1993) A well behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J Phys Chem 102:3787-3793.
8. 2 receptors of rat cerebral cortex. Gen Pharmacol 17:57-62.
9. Boess FG, Monsma FJ Jr, Meyer V, Zwingelstein C, and Sleight AJ (1997) Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptaminer receptor. Mol Pharmacol 52:515-523.
10. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
11. Cornell WD, Cieplak P, Bayly C, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, and Kollmann PA (1995) A second generation force field for the simulation of proteins, nucleic acids and organic molecules. J Am Chem Soc 117:5179-5197.
12. 2C receptors. Psychopharmacology (Berl) 136:409-414.
13. 1 receptors: synthesis and structure-activity relationships. Eur J Med Chem 35:41-52.
14. 1-receptor agonists. J Med Chem 43:1071-1084.
15. 1 receptor gene. Biochem Biophys Res Commun 201:894-901.
16. Gantz I, Munzert G, Tashiro T, Schaffer M, Wang L, Del Valle J, and Yamada T (1991) Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun 178:1386-1392.
17. Green JP, Johnson CL, Weinstein H, and Maayani S (1977) Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide. Proc Natl Acad Sci USA 74:5697-5701.
18. q subfamily of guanine nucleotide-binding regulatory protein a subunits attenuate activation of phosphatidylinositol 4,5-bisphosphate hydrolysis by hormones. J Biol Chem 266:20519-20524.
19. Herrmann WM, Horowski R, Dannehl K, Kramer U, and Lurati K (1977) Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide. Headache 17:54-60.
20. Husak M, Kratochvil B, Sedmera P, Havlicek V, Votavova H, Cvak L, Bulej P, and Jegorov A (1998) Molecular structure of cis- and trans-tergurides. Collection Czechoslovak Chem Commun 63:425-433.
21. 1 receptors in complex partial seizures. Lancet 341:23819.
22. Leopoldt D, Harteneck C, and Nürnberg B (1997) G proteins endogenously expressed in Sf 9 cells: interactions with mammalian histamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 356:216-224.
23. 2 receptor stably expressed in Chinese hamster ovary cells. Br J Pharmacol 112:847-854.
24. 4) expressed in bone marrow. Mol Pharmacol 59:420-426.
25. 3 receptor. Mol Pharmacol 55:1101-1107.
26. Majno G and Palade GE (1961) Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 11:571-605.
27. Malinowska B, Piszcz J, Schlicker E, Kramer K, Elz S, and Schunack W (1999) Histaprodifen, methylhistaprodifen and dimethylmstaprodifen are potent H1-receptor agonists in the pithed and in the anaesthetized rat. Naunyn-Schmiedeberg's Arch Pharmacol 359:11-16.
28. 1 receptor agonists in a modified mouse passive avoidance test. Neurosci Lett 288:1-4.
29. 1 receptor activation in rodents. Life Sci 63:463-476.
30. Mantegani S, Brambilla E, and Varasi M (1999) Ergoline derivatives: receptor affinity and selectivity. Farmaco 54:288-296.
31. 1A receptor-mediated behavioral effects overlap its other properties in rats. Psychopharmacology (Berl) 164:93-107.
32. Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, and Newman-Tancredi A (2002) Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther 303:791-804.
33. 1 histaminic receptor, in Animal Cell Technology: Basic & Applied Aspects (Nagai K and Wachi M eds) pp 65-69, Kluwer Academic Publishers, Dordrecht, The Netherlands.
34. 1 histamine receptor stably expressed in CHO cells. J Recept Signal Transduct Res 15:91-102.
35. 194. Biochem Biophys Res Commun 203:1096-1101.
36. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science (Wash DC) 289:739-745.
37. Peggs JF, Shimp LA, and Opdycke RA (1995) Antihistamines: the old and the new. Am Fam Physician 52:593-600.
38. 123I-iodolisuride SPECT in degenerative extrapyramidal diseases. Nucl Med Commun 22:1207-1214.
39. 1 antihistamines. J Clin Psychopharmacol 22:511-515.
40. Scherkl R, Hashem A, and Frey HH (1991) Importance of histamine for seizure susceptibility. Agents Actions Suppl 33:85-89.
41. 1-receptor agonists in the pithed and in the anaesthetized rat. Naunyn-Schmiedeberg's Arch Pharmacol 364:14-20.
42. Schmidt MW, Balderidge KK, Boatz JA, Elbert ST, Gordon MS, Jensen JH, Koseki S, Matsunage N, Nguyen KA, Su SJ, et al. (1993) A general atomic and molecular electronic structure system. J Comput Chem 14:1347-1363.
43. Schwartz JF and Patterson JH (1978) Am J Dis Child 132:37.
44. 1-receptor. J Pharmacol Exp Ther 305:1104-1115.
45. 1-antihistamines. Clin Allergy Immunol 17:141-178.
46. Stocchi F, Ruggieri S, Vacca L, and Olanow CW (2002) Prospective randomized trial of lisuride infusion versus oral leyodopa in patients with Parkinson's disease. Brain 125:2058-2066.
47. 1 receptors in human brain. Life Sci 72:409-414.
48. Topiol S and Sabio M (1991) The computational design of test compounds with potentially specific biological activity: histamine-H2 agonists derived from 5-HT/H2 antagonists. J Comput Aided Mol Des 5:263-272.
49. Tuomisto L and Tacke U (1986) Is histamine an anticonvulsive inhibitory transmitter? Neuropharmacology 25:955-958.
50. Walter LA, Hunt WH, and Fosbinder RJ (1941) β-(2- and 4-pyridylalkyl)-amines. J Am Chem Soc 63:2771-2773.
51. Watson C, Chen G, Irving P, Way J, Chen WJ, and Kenakin T (2000) The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists. Mol Pharmacol 58:1230-1238.
52. 2A receptor inverse agonists as antipsychotics. J Pharmacol Exp Ther 299:268-276.
53. 3 receptor. Neuropharmacology 42:929-940.
54. Windaus A and Vogt W (1907) Synthese des Imidazolyl-äthylamins Ber Dtsch Chem Ges 40:3691-3695.
55. Woosley RL (1996) Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 36:233-252.
56. Yokoyama H, Onodera K, Iinuma K, and Watanabe T (1993) Proconvulsive effects of histamine H1-antagonists on electrically-induced seizure in developing mice. Psychopharmacology 112:199-203.
57. 1 agonist, decreases seizure susceptibility in mice. Pharmacol Biochem Behav 47:503-507.
58. Yokoyama H, Onodera K, Maeyama K, Yanai K, Iinuma K, Tuomisto L, and Watanabe T (1992) Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of alpha-fluoromethylhistidine and metoprine. Naunyn-Schmiedeberg's Arch Pharmacol 346:40-45.
59. 1-receptor agonists. Prog Drug Res 44:49-85.